{"resourceType":"ValueSet","id":"2.16.840.1.113762.1.4.1221.12","meta":{"versionId":"5","lastUpdated":"2020-06-03T01:00:20.000-04:00"},"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1221.12","version":"20200603","name":"Contraceptive Transdermal Patch","status":"active","date":"2020-06-03T01:00:20-04:00","publisher":"NACHC Steward","compose":{"include":[{"system":"http://www.nlm.nih.gov/research/umls/rxnorm","version":"05022022","concept":[{"code":"1536581","display":"Xulane"},{"code":"1536582","display":"ethinyl estradiol 0.00146 MG/HR / norelgestromin 0.00625 MG/HR [Xulane]"},{"code":"1536584","display":"Xulane Topical Product"},{"code":"1536585","display":"Xulane Transdermal Product"},{"code":"1536586","display":"168 HR ethinyl estradiol 0.00146 MG/HR / norelgestromin 0.00625 MG/HR Transdermal System [Xulane]"},{"code":"1806243","display":"ethinyl estradiol / norelgestromin Transdermal System [Xulane]"}]}]}}